MARKET

SNY

SNY

Sanofi FR
NASDAQ
48.23
-0.23
-0.47%
After Hours: 48.23 0 0.00% 19:31 01/02 EST
OPEN
48.32
PREV CLOSE
48.46
HIGH
48.48
LOW
48.15
VOLUME
1.39M
TURNOVER
--
52 WEEK HIGH
57.58
52 WEEK LOW
44.62
MARKET CAP
117.40B
P/E (TTM)
21.51
1D
5D
1M
3M
1Y
5Y
1D
Trump Weekly: Furniture tariffs delayed, drugmakers hike prices
TipRanks · 18h ago
REGN Soars 41% in Six Months: Is There More Upside Potential in 2026?
NASDAQ · 23h ago
Midday Fly By: Nvidia said to see strong H200 demand in China
TipRanks · 12/31/2025 17:00
Pfizer (PFE) Tops List as Drugmakers Plan Price Hike on 350 Medications
TipRanks · 12/31/2025 15:02
Trump Trade: 350 drugs to see price raises despite President’s pressure
TipRanks · 12/31/2025 14:55
Drugmakers raise U.S. prices on 350 drugs despite Trump pressure, Reuters says
TipRanks · 12/31/2025 14:00
Drugmakers Plan Fresh Price Hikes On 350 Medicines In 2026
Benzinga · 12/31/2025 13:59
Pfizer, GSK and other drugmakers eying U.S. price hikes for 350 medicines: report
Seeking Alpha · 12/31/2025 13:22
More
About SNY
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Webull offers Sanofi SA (ADR) stock information, including NASDAQ: SNY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNY stock methods without spending real money on the virtual paper trading platform.